Shilpa Medicare Ltd
Mr Seshu Akula is a seasoned pharmaceutical industry professional with 32+ years Senior Level leadership experience. Seshu worked in various leadership positions with responsibilities including PnL Management, New Business Creation, Portfolio Strategy, Business Planning and Operational strategy, Corporate business development. His deep understanding of various business verticals including the API’s, Finished Dosages, Disease categories, Brand marketing, IP Landscape, Portfolio Strategy & product selection, Development and regulatory nuances with established front-end sales and commercial skills lead to several success stories in the industry. Seshu’s last 21 years are based in the US and his previous 11 years in the Indian and other Global markets.
Seshu hold an undergrduate degree in B Pharmacy ( Hons) from BITS-Pilani and an M.B.A from the TAPMI Management School.
This person is not in any offices
Shilpa Medicare Ltd
Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation. The Company's segments include Bulk Drug/Intermediates and Energy. It offers 3a 7b Dihydroxy. The Company deals with APIs, Intermediates, Formulations, New Drug Delivery Systems, Peptides/Biotech products and Specialty Chemicals. The Company supplies oncology/non-oncology APIs and intermediates. Its oncology API products include Anastrozole, Axitinib, Azacitidine, Abiraterone Acetate, Bicalutamide, Bortezomib, Busulphan, Cabazitaxel Amorphous, Capecitabine, Carboplatin, Cladribine, Clofarabine, Zoledronic acid, Vismodegib, Pemetrexed DiPotassium Nonahydrate, Cyclophosphamide Monohydrate and Cytarabine. It also offers AntiRetroVirals. Its non-oncology API products include Acebrophylline, Echothiophate, Nifedipine, Perfenidone, PrucaloprideSuccinate, Sildenafil Citrate, Ursodeoxycholic acid and Dimethyl Fumarate.